Role of methylenetetrahydrofolate reductase gene (MTHFR) 677C>T polymorphism in pediatric cerebrovascular disorders

Journal of Child Neurology

Volumn 26, Issue 3, 2011, Pages 318-321

  Alsayouf, Hamza ^a   Zamel, Khaled M ^a   Heyer, Geoffrey L ^a   Khuhro, A Latif ^a   Kahwash, Samir B ^a   De Los Reyes, Emily C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

cerebrovascular disorders; methylenetetrahydrofolate reductase (MTHFR); stroke

Indexed keywords

ADOLESCENT; ARTICLE; CEREBROVASCULAR DISEASE; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MIGRAINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST;

ADOLESCENT; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PEDIATRICS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952650966     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810381446     Document Type: Article

References (26)

1. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
2. Prengler M, Sturt N, Krywawych S, et al. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinemia, CVD and stroke in childhood. Dev Med Child Neurol. 2001;43:220-225.
3. Cardo E, Monros E, Colome C, et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia and vitamin status. J Child Neurol. 2000;15:295-298. (Pubitemid 30341360)
4. Pezzini A, Del Zotto E, Archetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664-669.
5. Kara I, Sazci A, Ergul E, et al. Association of the C677T and A1298C polymorphisms in the 677C>T methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003;111:84-90. (Pubitemid 36332332)
6. Kowa H, Yasui K, Takeshima T, et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor formigraine. Am JMed Genet. 2000;96:762-764.
7. Harker LA, Ross R, Slichter SJ, et al. Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genetics. J Clin Invest. 1976;58:731-741.
8. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121. (Pubitemid 10109903)
9. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91: 308-318. (Pubitemid 23037286)
10. Cooke JP, Tsao PS. Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994;14:653-655.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl):S1-S96.
12. Bernard PS, Lay MJ, Wittwer CT. Integrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves. Anal Biochem. 1998;255:101-107. (Pubitemid 28047624)
13. Arruda VR, von Zuben PM, Chiaparini LC, et al. The mutation A1a677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost. 1997;77:818-821. (Pubitemid 27239096)
14. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1-7.
15. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA. 2002;288:2015-2020.
16. Konrad C, Müller GA, Langer C, et al. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol. 2004;251:1242-1248. (Pubitemid 39517928)
17. Pezzini A, Del Zotto E, Padovani A. Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine.JNeurol. 2002;249:1401-1403.
18. Caso V, Cardaioli G, Gallai V, Parnetti L. Vertebral artery dissection and hyperhomocysteinemia: a case report. Cerebrovasc Dis. 2000;10(suppl 4):S9-S11.
19. Gallai V, Caso V, Paciaroni M, et al. Mild hyperhomocysteinemia: a possible risk factor for cervical artery dissection. Stroke. 2001;32:714-718.
20. Lea RA, Ovcaric M, Sundholm J, et al. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004;2:3.
21. Oterino A, Valle N, Bravo Y, et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004;24:491-494. (Pubitemid 38748031)
22. Cupini LM, Stipa E. Migraine aura status and hyperhomocysteinemia. Cephalalgia. 2007;27:847-849.
23. Di Rosa G. Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms. Headache. 2007; 47:1342-1344. (Pubitemid 47561535)
24. Signorello MG, Segantin A, Passalacqua M, Leoncini G. Homocysteine decreases platelet NO level via protein kinase activation. Nitric Oxide. 2009;20:104-113.
25. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol. 2004;142:1171-1181. (Pubitemid 39093014)
26. Pettigrew LC, Bang H, Chambless LE, et al. Vitamin Intervention for Stroke Prevention Investigators. Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial. Atherosclerosis. 2008;200:345-349.